Retrieve available abstracts of 10 articles: HTML format
Single Articles
September 2025
CHEN N, Feng L, Qu H, Lu K, et al [Corrigendum] Overexpression of IL?9 induced by STAT3 phosphorylation is mediated
by miR?155 and miR?21 in chronic lymphocytic leukemia.
Oncol Rep. 2025;54:107. PubMedAbstract available
August 2025
LI L, Gorgens A, Mussack V, Pepeldjiyska E, et al Role of extracellular vesicles as promotors for activation of leukemia?derived
dendritic cell?mediated antileukemic immune response against AML?blasts.
Oncol Rep. 2025;54:99. PubMedAbstract available
July 2025
WANG C, Yang X, Shen X, Yan S, et al SNX10 regulates the proliferation, apoptosis and cell cycle of acute B
lymphoblastic leukemia cells via the PI3K/Akt signaling pathway.
Oncol Rep. 2025;54:78. PubMedAbstract available
May 2025
QIU H, Zhang C, Ma X, Li Y, et al Molecular insights and treatment innovations: Advancing outcomes in acute myeloid
leukemia with myelodysplasia?related changes (Review).
Oncol Rep. 2025;53:54. PubMedAbstract available
March 2025
LIU YH, Zhu M, Lei PP, Pan XY, et al [Corrigendum] ND?09 inhibits chronic myeloid leukemia K562 cell growth by
regulating BCR?ABL signaling.
Oncol Rep. 2025;53:37. PubMedAbstract available
November 2024
CHEN L, Zeng P, Tang H, Chen G, et al Routes and molecular mechanisms of central nervous system involvement in acute
myeloid leukemia (Review).
Oncol Rep. 2024;52:146. PubMedAbstract available
August 2024
MORINO Y, Sugiyama H, Yamane K, Kikuchi M, et al Additive antitumor effect of arsenic trioxide with exposure to ionizing radiation
to human acute promyelocytic leukemia HL?60 cells.
Oncol Rep. 2024;52:109. PubMedAbstract available
July 2024
IDA N, Okura M, Tanaka S, Hosono N, et al Combining inotuzumab ozogamicin with PARP inhibitors olaparib and talazoparib
exerts synergistic cytotoxicity in acute lymphoblastic leukemia by inhibiting DNA
strand break repair.
Oncol Rep. 2024;52:90. PubMedAbstract available
May 2024
TENG Z, Xu S, Lei Q [Retracted] Tanshinone IIA enhances the inhibitory effect of imatinib on
proliferation and motility of acute leukemia cell line TIB?152 in vivo and
in vitro by inhibiting the PI3K/AKT/mTOR signaling pathway.
Oncol Rep. 2024;51:66. PubMedAbstract available
December 2023
LI J, Tang B, Miao Y, Li G, et al Targeting of STAT5 using the small molecule topotecan hydrochloride suppresses
acute myeloid leukemia progression.
Oncol Rep. 2023;50:208. PubMedAbstract available